Response to "Influence of Diabetes on Antiplatelet Drug Efficacy"

Clin Pharmacol Ther. 2018 Apr;103(4):573. doi: 10.1002/cpt.1002. Epub 2018 Feb 22.

Authors

Aleksi Tornio¹, Colin N A Palmer², Alex S F Doney³

Affiliations

¹ Department of Clinical Pharmacology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
² Pat MacPherson Centre for Pharmacogenetics and Pharmacogenomics, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.
³ Medicines Monitoring Unit, University of Dundee, Ninewells Hospital and Medical School, Dundee, UK.

PMID: 29468659
DOI: 10.1002/cpt.1002

No abstract available

Publication types

Letter
Comment

MeSH terms

Clopidogrel
Electronic Health Records
Humans
Pharmacogenetics
Platelet Aggregation Inhibitors*
Stroke*

Substances

Platelet Aggregation Inhibitors
Clopidogrel